Works matching IS 15228517 AND DT 2022 AND VI 24 AND IP 11

Results: 27

Society News.

Published in:: Neuro-Oncology, 2022, v. 24, n. 11, p. 2013, doi. 10.1093/neuonc/noac228
Publication type:: Article

Hurdling over the blood–brain barrier with exosome technology.

Published in:

Neuro-Oncology, 2022, v. 24, n. 11, p. 1884, doi. 10.1093/neuonc/noac214

By:

Felker, James;
Agnihotri, Sameer

Publication type:

Article

Improved survival among females and association with lymphopenia in patients with newly diagnosed glioblastoma.

Published in:

Neuro-Oncology, 2022, v. 24, n. 11, p. 2005, doi. 10.1093/neuonc/noac190

By:

Shi, Diana D;
Youssef, Gilbert C;
Nassar, Amin H;
Lim-Fat, Mary Jane;
Ligon, Keith L;
Wen, Patrick Y;
Rahman, Rifaquat

Publication type:

Article

Erratum to: Environmental and sex-specific molecular signatures of glioma causation.

Published in:: 2022
Publication type:: Correction Notice

Corrigendum to: A preclinical model of patient-derived cerebrospinal fluid circulating tumor cells for experimental therapeutics in leptomeningeal disease from melanoma.

Published in:: 2022
Publication type:: Correction Notice

Corrigendum to: TERT promoter C228T mutation in neural progenitors confers growth advantage following telomere shortening in vivo.

Published in:: 2022
Publication type:: Correction Notice

fifth edition of the World Health Organization Classification of Tumors of the Central Nervous System: Implications for cancer registries.

Published in:

2022

By:

Hoogendijk, Raoull;
van der Lugt, Jasper;
Hoving, Eelco;
Kremer, Leontien;
Visser, Otto;
Wesseling, Pieter;
Vuurden, Dannis van;
Karim-Kos, Henrike

Publication type:

Editorial

Improved seizure control in patients with recurrent glioblastoma treated with bevacizumab.

Published in:

Neuro-Oncology, 2022, v. 24, n. 11, p. 2001, doi. 10.1093/neuonc/noac172

By:

Hertler, Caroline;
Seystahl, Katharina;
Rhun, Emilie Le;
Wirsching, Hans-Georg;
Roth, Patrick;
Weller, Michael;
Gramatzki, Dorothee

Publication type:

Article

MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus.

Published in:

Neuro-Oncology, 2022, v. 24, n. 11, p. 1845, doi. 10.1093/neuonc/noac165

By:

Blank, Peter M K de;
Gross, Andrea M;
Akshintala, Srivandana;
Blakeley, Jaishri O;
Bollag, Gideon;
Cannon, Ashley;
Dombi, Eva;
Fangusaro, Jason;
Gelb, Bruce D;
Hargrave, Darren;
Kim, AeRang;
Klesse, Laura J;
Loh, Mignon;
Martin, Staci;
Moertel, Christopher;
Packer, Roger;
Payne, Jonathan M;
Rauen, Katherine A;
Rios, Jonathan J;
Robison, Nathan

Publication type:

Article

BRAF inhibitors in BRAFV600E-mutated pediatric high-grade gliomas: Upfront or at recurrence?

Published in:

Neuro-Oncology, 2022, v. 24, n. 11, p. 1976, doi. 10.1093/neuonc/noac160

By:

Nobre, Liana;
Bouffet, Eric

Publication type:

Article

Targeting neddylation in cancer.

Published in:

Neuro-Oncology, 2022, v. 24, n. 11, p. 1869, doi. 10.1093/neuonc/noac159

By:

Goenka, Anshika;
Cheng, Shi-Yuan

Publication type:

Article

Molecular biomarker-defined brain tumors: Epidemiology, validity, and completeness in the United States.

Published in:

Neuro-Oncology, 2022, v. 24, n. 11, p. 1989, doi. 10.1093/neuonc/noac113

By:

Iorgulescu, J Bryan;
Sun, Chuxuan;
Neff, Corey;
Cioffi, Gino;
Gutierrez, Catherine;
Kruchko, Carol;
Ruhl, Jennifer;
Waite, Kristin A;
Negoita, Serban;
Hofferkamp, Jim;
Tihan, Tarik;
McLendon, Roger;
Brat, Daniel J;
Ostrom, Quinn T;
Barnholtz-Sloan, Jill S

Publication type:

Article

Erratum to: Cancer cell heterogeneity and plasticity: A paradigm shift in glioblastoma.

Published in:: 2022
Publication type:: Correction Notice

Investigational PET tracers in neuro-oncology—What's on the horizon? A report of the PET/RANO group.

Published in:

Neuro-Oncology, 2022, v. 24, n. 11, p. 1815, doi. 10.1093/neuonc/noac131

By:

Galldiks, Norbert;
Langen, Karl-Josef;
Albert, Nathalie L;
Law, Ian;
Kim, Michelle M;
Villanueva-Meyer, Javier E;
Soffietti, Riccardo;
Wen, Patrick Y;
Weller, Michael;
Tonn, Joerg C

Publication type:

Article

CNS non-germinomatous germ cell tumor (NGGCT): Lessons from the recent past.

Published in:

Neuro-Oncology, 2022, v. 24, n. 11, p. 1962, doi. 10.1093/neuonc/noac119

By:

Yeo, Kee Kiat;
MacDonald, Shannon M

Publication type:

Article

Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter.

Published in:

Neuro-Oncology, 2022, v. 24, n. 11, p. 1935, doi. 10.1093/neuonc/noac116

By:

Lim, Michael;
Weller, Michael;
Idbaih, Ahmed;
Steinbach, Joachim;
Finocchiaro, Gaetano;
Raval, Raju R;
Ansstas, George;
Baehring, Joachim;
Taylor, Jennie W;
Honnorat, Jerome;
Petrecca, Kevin;
Vos, Filip De;
Wick, Antje;
Sumrall, Ashley;
Sahebjam, Solmaz;
Mellinghoff, Ingo K;
Kinoshita, Masashi;
Roberts, Mustimbo;
Slepetis, Ruta;
Warad, Deepti

Publication type:

Article

Management of neurofibromatosis type 1-associated plexiform neurofibromas.

Published in:

Neuro-Oncology, 2022, v. 24, n. 11, p. 1827, doi. 10.1093/neuonc/noac146

By:

Fisher, Michael J;
Blakeley, Jaishri O;
Weiss, Brian D;
Dombi, Eva;
Ahlawat, Shivani;
Akshintala, Srivandana;
Belzberg, Allan J;
Bornhorst, Miriam;
Bredella, Miriam A;
Cai, Wenli;
Ferner, Rosalie E;
Gross, Andrea M;
Harris, Gordon J;
Listernick, Robert;
Ly, Ina;
Martin, Staci;
Mautner, Victor F;
Salamon, Johannes M;
Salerno, Kilian E;
Spinner, Robert J

Publication type:

Article

Imaging biomarkers of TERT or GABPB1 silencing in TERT-positive glioblastoma.

Published in:

Neuro-Oncology, 2022, v. 24, n. 11, p. 1898, doi. 10.1093/neuonc/noac112

By:

Minami, Noriaki;
Hong, Donghyun;
Stevers, Nicholas;
Barger, Carter J;
Radoul, Marina;
Hong, Chibo;
Chen, Lee;
Kim, Yaewon;
Batsios, Georgios;
Gillespie, Anne Marie;
Pieper, Russel O;
Costello, Joseph F;
Viswanath, Pavithra;
Ronen, Sabrina M

Publication type:

Article

MEOX2 homeobox gene promotes growth of malignant gliomas.

Published in:

Neuro-Oncology, 2022, v. 24, n. 11, p. 1911, doi. 10.1093/neuonc/noac110

By:

Schönrock, Anna;
Heinzelmann, Elisa;
Steffl, Bianca;
Demirdizen, Engin;
Narayanan, Ashwin;
Krunic, Damir;
Bähr, Marion;
Park, Jong-Whi;
Schmidt, Claudia;
Özduman, Koray;
Pamir, M Necmettin;
Wick, Wolfgang;
Bestvater, Felix;
Weichenhan, Dieter;
Plass, Christoph;
Taranda, Julian;
Mall, Moritz;
Turcan, Şevin

Publication type:

Article

Blood exosomes-based targeted delivery of cPLA2 siRNA and metformin to modulate glioblastoma energy metabolism for tailoring personalized therapy.

Published in:

Neuro-Oncology, 2022, v. 24, n. 11, p. 1871, doi. 10.1093/neuonc/noac071

By:

Zhan, Qi;
Yi, Kaikai;
Cui, Xiaoteng;
Li, Xueping;
Yang, Shixue;
Wang, Qixue;
Fang, Chuan;
Tan, Yanli;
Li, Lijie;
Xu, Can;
Yuan, Xubo;
Kang, Chunsheng

Publication type:

Article

DNA methylation subclass receptor tyrosine kinase II (RTK II) is predictive for seizure development in glioblastoma patients.

Published in:

Neuro-Oncology, 2022, v. 24, n. 11, p. 1886, doi. 10.1093/neuonc/noac108

By:

Ricklefs, Franz L;
Drexler, Richard;
Wollmann, Kathrin;
Eckhardt, Alicia;
Heiland, Dieter H;
Sauvigny, Thomas;
Maire, Cecile;
Lamszus, Katrin;
Westphal, Manfred;
Schüller, Ulrich;
Dührsen, Lasse

Publication type:

Article

Factors correlating with survival following adjuvant or definitive radiosurgery for large brain metastases.

Published in:

Neuro-Oncology, 2022, v. 24, n. 11, p. 1925, doi. 10.1093/neuonc/noac106

By:

Gutiérrez-Valencia, Enrique;
Kalyvas, Aristotelis;
Villafuerte, Conrad J;
Millar, Barbara-Ann;
Laperriere, Normand;
Conrad, Tatiana;
Berlin, Alejandro;
Weiss, Jessica;
Zadeh, Gelareh;
Bernstein, Mark;
Kongkham, Paul;
Shultz, David B

Publication type:

Article

Erratum to: path-03. Ferroptosis-related long non-coding rna signatures predict prognosis in patients with glioma.

Published in:: 2022
Publication type:: Correction Notice

Upfront molecular targeted therapy for the treatment of BRAF-mutant pediatric high-grade glioma.

Published in:

Neuro-Oncology, 2022, v. 24, n. 11, p. 1964, doi. 10.1093/neuonc/noac096

By:

Rosenberg, Tom;
Yeo, Kee Kiat;
Mauguen, Audrey;
Alexandrescu, Sanda;
Prabhu, Sanjay P;
Tsai, Jessica W;
Malinowski, Seth;
Joshirao, Mrinal;
Parikh, Karishma;
Sait, Sameer Farouk;
Rosenblum, Marc K;
Benhamida, Jamal K;
Michaiel, George;
Tran, Hung N;
Dahiya, Sonika;
Kachurak, Kara;
Friedman, Gregory K;
Krystal, Julie I;
Huang, Michael A;
Margol, Ashley S

Publication type:

Article

Selumetinib in children with neurofibromatosis type 1 and asymptomatic inoperable plexiform neurofibroma at risk for developing tumor-related morbidity.

Published in:

Neuro-Oncology, 2022, v. 24, n. 11, p. 1978, doi. 10.1093/neuonc/noac109

By:

Gross, Andrea M;
Glassberg, Brittany;
Wolters, Pamela L;
Dombi, Eva;
Baldwin, Andrea;
Fisher, Michael J;
Kim, AeRang;
Bornhorst, Miriam;
Weiss, Brian D;
Blakeley, Jaishri O;
Whitcomb, Patricia;
Paul, Scott M;
Steinberg, Seth M;
Venzon, David J;
Martin, Staci;
Carbonell, Amanda;
Heisey, Kara;
Therrien, Janet;
Kapustina, Oxana;
Dufek, Anne

Publication type:

Article

Pattern of treatment failures in patients with central nervous system non-germinomatous germ cell tumors (CNS-NGGCT): A pooled analysis of clinical trials.

Published in:

Neuro-Oncology, 2022, v. 24, n. 11, p. 1950, doi. 10.1093/neuonc/noac057

By:

Fonseca, Adriana;
Faure-Conter, Cecile;
Murray, Matthew J;
Fangusaro, Jason;
Bailey, Shivani;
Goldman, Stewart;
Khatua, Soumen;
Frappaz, Didier;
Calaminus, Gabriele;
Dhall, Girish;
Nicholson, James C;
Bouffet, Eric;
Bartels, Ute

Publication type:

Article

PTEN loss drives resistance to the neddylation inhibitor MLN4924 in glioblastoma and can be overcome with TOP2A inhibitors.

Published in:

Neuro-Oncology, 2022, v. 24, n. 11, p. 1857, doi. 10.1093/neuonc/noac067

By:

Ferdosi, Shayesteh R;
Taylor, Brett;
Lee, Matthew;
Tang, Nanyun;
Peng, Sen;
Bybee, Rita;
Reid, George;
Hartman, Lauren;
Garcia-Mansfield, Krystine;
Sharma, Ritin;
Pirrotte, Patrick;
Ma, Jianhui;
Parisian, Alison D;
Furnari, Frank;
Dhruv, Harshil D;
Berens, Michael E

Publication type:

Article